Skip to content
sellWeak cluster of 2

Mark C. Schiller sold $2,401 of KZR

Chief Operating Officer at Kezar Life Sciences, Inc.. 561 shares at an average of $4.28, traded Jul 2, 2025, filed Jul 3, 2025.

Warning score
33
Value
$2,401
561 shares
Holdings after
2,739
-17% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    COO
    +20
  • Trade size
    $2k at market
    0
  • Share of holdings sold
    Sold 17% of holdings
    +5
  • Cluster
    2 insiders selling within 14 days
    +8

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001415889-25-019310, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jul 2, 2025SOpen-market sale
Common Stock
-561$4.28$2,4012,739Jul 3, 2025

Related signals

Other insiders at Kezar Life Sciences, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
23Weak
KZRsell 2
Kezar Life Sciences, Inc.
Pichi Luo Chiang
SVP, Corporate Controller
$1,130
264 shares
-9%
20Weak
KZRsell
Kezar Life Sciences, Inc.
Mark C. Schiller
Chief Legal Officer
$3,879
6,688 shares
-17%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mark C. Schiller sold $2,401 of KZR | InsiderTell